cytidine diphosphate choline has been researched along with galantamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deutsch, SI; Gaskins, BL; Long, KD; Mastropaolo, J; Rosse, RB; Schooler, NR; Schwartz, BL | 1 |
| Brown, CH; Deutsch, SI; Rosse, RB; Rosse, SM; Schooler, NR; Schwartz, BL | 1 |
| Blais, CM; Choueiry, J; Fisher, D; Illivitsky, V; Knott, V; Shah, D; Smith, D | 1 |
| Blais, CM; Choueiry, J; Fisher, D; Knott, V; Labelle, A; Shah, D; Smith, D | 1 |
3 trial(s) available for cytidine diphosphate choline and galantamine
| Article | Year |
|---|---|
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.
Topics: Adult; Aged; alpha7 Nicotinic Acetylcholine Receptor; Cognition Disorders; Cytidine Diphosphate Choline; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Synaptic Transmission; Treatment Outcome | 2013 |
CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Auditory Cortex; Auditory Perception; Cross-Over Studies; Cytidine Diphosphate Choline; Double-Blind Method; Drug Delivery Systems; Electroencephalography; Evoked Potentials, Auditory; Female; Galantamine; Healthy Volunteers; Humans; Male; Nootropic Agents; Pilot Projects; Speech; Speech Perception | 2020 |
An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Cytidine Diphosphate Choline; Galantamine; Humans; Nicotinic Agonists; Nootropic Agents; Pilot Projects; Schizophrenia | 2023 |
1 other study(ies) available for cytidine diphosphate choline and galantamine
| Article | Year |
|---|---|
Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cholinesterase Inhibitors; Cytidine Diphosphate Choline; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Galantamine; Male; Mice; Nootropic Agents; Schizophrenia | 2008 |